Literature DB >> 3917323

Audit of control of heparin treatment.

A G Fennerty, P Thomas, G Backhouse, P Bentley, I A Campbell, P A Routledge.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3917323      PMCID: PMC1415373          DOI: 10.1136/bmj.290.6461.27-a

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


× No keyword cloud information.
  4 in total

1.  Management of heparin therapy: Controlled prospective trial.

Authors:  E W Salzman; D Deykin; R M Shapiro; R Rosenberg
Journal:  N Engl J Med       Date:  1975-05-15       Impact factor: 91.245

2.  A prospective study of the value of monitoring heparin treatment with the activated partial thromboplastin time.

Authors:  D Basu; A Gallus; J Hirsh; J Cade
Journal:  N Engl J Med       Date:  1972-08-17       Impact factor: 91.245

3.  Determinants of the anticoagulant effect of heparin in vitro.

Authors:  T D Bjornsson; K M Wolfram
Journal:  Ann N Y Acad Sci       Date:  1981       Impact factor: 5.691

4.  Heparin kinetics in venous thrombosis and pulmonary embolism.

Authors:  J Hirsh; W G van Aken; A S Gallus; C T Dollery; J F Cade; W L Yung
Journal:  Circulation       Date:  1976-04       Impact factor: 29.690

  4 in total
  14 in total

Review 1.  Recognition and treatment of unstable angina.

Authors:  C Brunelli; P Spallarossa; P Rossettin; S Caponnetto
Journal:  Drugs       Date:  1996-08       Impact factor: 9.546

Review 2.  The Smith Kline & French lecture 1987. Clinical pharmacology and the art of bespoke prescribing.

Authors:  P A Routledge
Journal:  Br J Clin Pharmacol       Date:  1988-10       Impact factor: 4.335

Review 3.  Anticoagulants in venous thromboembolism.

Authors:  A Fennerty; I A Campbell; P A Routledge
Journal:  BMJ       Date:  1988-11-19

Review 4.  Intravenous heparin dosing: patterns and variations in internists' practices.

Authors:  B M Reilly; R Raschke; S Srinivas; T Nieman
Journal:  J Gen Intern Med       Date:  1993-10       Impact factor: 5.128

Review 5.  Pharmacokinetic optimisation of the treatment of deep vein thrombosis.

Authors:  A Iorio; G Agnelli
Journal:  Clin Pharmacokinet       Date:  1997-02       Impact factor: 6.447

6.  Treatment of Venous Thromboembolism with Low-Molecular-Weight Heparin.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1995       Impact factor: 2.300

7.  New method to predict patients' intravenous heparin dose requirements.

Authors:  B M Reilly; R A Raschke
Journal:  J Gen Intern Med       Date:  1996-03       Impact factor: 5.128

Review 8.  Heparin therapy. Regimens and treatment considerations.

Authors:  T M Hyers
Journal:  Drugs       Date:  1992-11       Impact factor: 9.546

Review 9.  Prevention and treatment of venous thromboembolism.

Authors:  G F Pineo; R D Hull
Journal:  Drugs       Date:  1996-07       Impact factor: 9.546

10.  Advances in the treatment of cerebral venous thrombosis.

Authors:  J M Coutinho; S Middeldorp; J Stam
Journal:  Curr Treat Options Neurol       Date:  2014-07       Impact factor: 3.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.